Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: a clinical benefit-oriented phase II study-Reference-Cited by-同舟云学术

Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: a clinical benefit-oriented phase II study

Published:2000 Issue:11 Volume:82 Page:1772-1775
ISSN:1532-1827
Container-title:British Journal of Cancer
language:
Short-container-title:Br J Cancer

Author:

Matano E,Tagliaferri P,Libroia A,Damiano V,Fabbrocini A,De Lorenzo S,Bianco A R

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference11 articles.

1. The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

3. Clinical Response Benefit in Patients with Advanced Pancreatic Cancer

4. Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Stem Cells in Carcinogenesis and Potential Role in Pancreatic Cancer;Current Stem Cell Research & Therapy;2023-09-14

2. Arterial Administration of DNA Crosslinking Agents with Restraint of Homologous Recombination Repair by Intravenous Low-Dose Gemcitabine Is Effective for Locally Advanced Pancreatic Cancer;Cancers;2022-01-03

3. Regulation of ABCG2 expression by Wnt5a through FZD7 in human pancreatic cancer cells;Molecular Medicine Reports;2020-11-16

4. Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase ABCG2 Expression;Cancers;2018-12-20

5. Isolation of circulating tumor cells in pancreatic cancer patients by immunocytochemical assay;Journal of Clinical Laboratory Analysis;2017-05-19